Evolution Wealth Advisors LLC Has $2.80 Million Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Evolution Wealth Advisors LLC grew its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 29,484 shares of the exchange traded fund’s stock after purchasing an additional 1,203 shares during the period. Evolution Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $2,798,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in XBI. Envestnet Asset Management Inc. boosted its position in SPDR S&P Biotech ETF by 5.8% during the 3rd quarter. Envestnet Asset Management Inc. now owns 126,001 shares of the exchange traded fund’s stock worth $9,201,000 after buying an additional 6,884 shares during the period. Synovus Financial Corp increased its stake in shares of SPDR S&P Biotech ETF by 9.3% in the 3rd quarter. Synovus Financial Corp now owns 5,018 shares of the exchange traded fund’s stock valued at $366,000 after acquiring an additional 429 shares in the last quarter. Alerus Financial NA increased its stake in shares of SPDR S&P Biotech ETF by 0.6% in the 3rd quarter. Alerus Financial NA now owns 54,655 shares of the exchange traded fund’s stock valued at $3,991,000 after acquiring an additional 349 shares in the last quarter. Sectoral Asset Management Inc. increased its stake in shares of SPDR S&P Biotech ETF by 36.8% in the 3rd quarter. Sectoral Asset Management Inc. now owns 24,675 shares of the exchange traded fund’s stock valued at $1,802,000 after acquiring an additional 6,643 shares in the last quarter. Finally, Scotia Capital Inc. increased its stake in SPDR S&P Biotech ETF by 4.9% during the 3rd quarter. Scotia Capital Inc. now owns 41,137 shares of the exchange traded fund’s stock valued at $3,004,000 after purchasing an additional 1,933 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI traded down $0.49 during mid-day trading on Wednesday, reaching $90.87. 4,671,912 shares of the stock were exchanged, compared to its average volume of 10,621,430. The stock has a market capitalization of $6.93 billion, a PE ratio of 11.47 and a beta of 1.11. The company has a 50 day moving average price of $90.27 and a two-hundred day moving average price of $90.94. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.